Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|March 14, 2008
Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII AnalogStephanie Planque, Miguel A Escobar, Keri C Smith, et al.
Annals of Clinical and Laboratory Science|December 21, 2016
Providing Hemostatic and Blood Conservation Options for Jehovah's Witness Patients in a Large Medical SystemYu Bai, Brian S Castillo, Amanda Tchakarov, et al.
Journal of Intensive Care Medicine|September 25, 2018
Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding PatientsTeresa A Allison, Pei Jen Lin, Jennifer A Gass, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2024
Retrospective chart review of GI bleeding in people with von Willebrand diseaseJonathan C Roberts, Miguel A Escobar, Suchitra Acharya, et al.
International Journal of Cardiology|August 12, 2016
Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the communityGema Ruiz, Jose L Andrey, Jose L Puerto, et al.
International Journal of Cardiology|May 8, 2012
Impact of new-onset diabetes mellitus and glycemic control on the prognosis of heart failure patients: a propensity-matched study in the communitySotero P Romero, Antonio Garcia-Egido, Miguel A Escobar, et al.
International Journal of Cardiology|June 17, 2010
Mortality of newly diagnosed heart failure treated with amiodarone A propensity-matched studyJose L Andrey, Francisco M Gomez-Soto, Sotero P Romero, et al.
International Journal of Cardiology|November 25, 2011
Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the communitySotero P Romero, Jose L Andrey, Antonio Garcia-Egido, et al.
International Journal of Cardiology|December 10, 2008
Mortality and morbidity of non-systolic heart failure treated with angiotensin-converting enzyme inhibitors: a propensity-adjusted case-control studyFrancisco M Gomez-Soto, Sotero P Romero, Jose A Bernal, et al.
Pageof 5